Panagora Asset Management’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
Other funds holding KYNB
AC
Panagora Asset Management's KYNB Position: Q2 2023 in Review
Panagora Asset Management sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 1,362 shares — an estimated $635K sold.
Panagora Asset Management first reported a position in KYNB in Q3 2015 and held it in 25 quarters. The position peaked at $11.1M in Q3 2017. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.
- Panagora Asset Management reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
- Panagora Asset Management sold 1,362 Kyntra Bio shares in Q2 2023, an estimated $635K.
- Panagora Asset Management first reported a position in Kyntra Bio in Q3 2015 and held it in 25 quarters.
- Panagora Asset Management's Kyntra Bio position peaked at $11.1M in Q3 2017.
- 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.
Based on Panagora Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.